版本:
中国

BRIEF-Rexahn Pharmaceuticals reports Q1 loss per share $0.09

May 4 Rexahn Pharmaceuticals Inc:

* Rexahn Pharmaceuticals reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.09

* Q1 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S

* Rexahn Pharmaceuticals - expects its current cash and investments will be sufficient to fund cash flow requirements for current activities into mid-2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐